BRK-B vs SBFG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
SBFG presents a compelling deep-value opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($22.54) that trades at a significant discount to both its Graham Number ($33.30) and Intrinsic Value ($59.35). The company demonstrates exceptional operational consistency, evidenced by a strong earnings beat track record over 25 consecutive quarters. While technical trends and insider sentiment are currently bearish, the fundamental valuation (P/B of 1.00 and P/E of 10.29) provides a substantial margin of safety. The combination of steady earnings growth and a sustainable dividend payout makes this a strong defensive play in the regional banking sector.
Compare Another Pair
Related Comparisons
BRK-B vs SBFG: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and SB Financial Group, Inc. (SBFG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.